SANOFI-ADR (SNY) Stock Fundamental Analysis

NASDAQ:SNY • US80105N1054

46.5731 USD
+0.43 (+0.94%)
Last: Feb 19, 2026, 10:31 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall SNY gets a fundamental rating of 5 out of 10. We evaluated SNY against 191 industry peers in the Pharmaceuticals industry. While SNY belongs to the best of the industry regarding profitability, there are concerns on its financial health. SNY has a correct valuation and a medium growth rate. Finally SNY also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year SNY was profitable.
  • In the past 5 years SNY has always been profitable.
  • SNY had a positive operating cash flow in each of the past 5 years.
SNY Yearly Net Income VS EBIT VS OCF VS FCFSNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SNY has a better Return On Assets (10.63%) than 92.15% of its industry peers.
  • SNY's Return On Equity of 18.84% is amongst the best of the industry. SNY outperforms 90.05% of its industry peers.
  • SNY's Return On Invested Capital of 13.35% is amongst the best of the industry. SNY outperforms 93.19% of its industry peers.
  • SNY had an Average Return On Invested Capital over the past 3 years of 7.41%. This is significantly below the industry average of 12.64%.
  • The last Return On Invested Capital (13.35%) for SNY is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SNY Yearly ROA, ROE, ROICSNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of SNY (20.63%) is better than 91.10% of its industry peers.
  • In the last couple of years the Profit Margin of SNY has declined.
  • With an excellent Operating Margin value of 23.61%, SNY belongs to the best of the industry, outperforming 90.58% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SNY has grown nicely.
  • Looking at the Gross Margin, with a value of 72.29%, SNY is in the better half of the industry, outperforming 79.58% of the companies in the same industry.
  • SNY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SNY Yearly Profit, Operating, Gross MarginsSNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SNY is creating some value.
  • The number of shares outstanding for SNY has been reduced compared to 1 year ago.
  • Compared to 5 years ago, SNY has less shares outstanding
  • The debt/assets ratio for SNY is higher compared to a year ago.
SNY Yearly Shares OutstandingSNY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
SNY Yearly Total Debt VS Total AssetsSNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SNY has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.18, SNY is in line with its industry, outperforming 44.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.7
WACC7.87%
SNY Yearly LT Debt VS Equity VS FCFSNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • SNY has a Current Ratio of 1.06. This is a normal value and indicates that SNY is financially healthy and should not expect problems in meeting its short term obligations.
  • SNY has a worse Current ratio (1.06) than 83.77% of its industry peers.
  • SNY has a Quick Ratio of 1.06. This is a bad value and indicates that SNY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SNY has a worse Quick ratio (0.30) than 91.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
SNY Yearly Current Assets VS Current LiabilitesSNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.82% over the past year.
  • SNY shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.58% yearly.
  • The Revenue has been growing slightly by 5.49% in the past year.
  • Measured over the past years, SNY shows a small growth in Revenue. The Revenue has been growing by 4.57% on average per year.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • SNY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.70% yearly.
  • The Revenue is expected to grow by 4.86% on average over the next years.
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SNY Yearly Revenue VS EstimatesSNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SNY Yearly EPS VS EstimatesSNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.97, the valuation of SNY can be described as reasonable.
  • 92.15% of the companies in the same industry are more expensive than SNY, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.27, SNY is valued rather cheaply.
  • A Price/Forward Earnings ratio of 9.22 indicates a reasonable valuation of SNY.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SNY indicates a rather cheap valuation: SNY is cheaper than 89.01% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.16, SNY is valued rather cheaply.
Industry RankSector Rank
PE 9.97
Fwd PE 9.22
SNY Price Earnings VS Forward Price EarningsSNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNY Per share dataSNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of SNY may justify a higher PE ratio.
PEG (NY)1.23
PEG (5Y)1.79
EPS Next 2Y6.92%
EPS Next 3Y8.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • SNY has a Yearly Dividend Yield of 5.21%, which is a nice return.
  • SNY's Dividend Yield is rather good when compared to the industry average which is at 1.18. SNY pays more dividend than 97.38% of the companies in the same industry.
  • SNY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 5.21%

5.2 History

  • The dividend of SNY has a limited annual growth rate of 4.30%.
  • SNY has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of SNY decreased in the last 3 years.
Dividend Growth(5Y)4.3%
Div Incr Years2
Div Non Decr Years2
SNY Yearly Dividends per shareSNY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • 34.36% of the earnings are spent on dividend by SNY. This is a low number and sustainable payout ratio.
  • SNY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.36%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
SNY Yearly Income VS Free CF VS DividendSNY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
SNY Dividend Payout.SNY Dividend Payout, showing the Payout Ratio.SNY Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI-ADR

NASDAQ:SNY (2/19/2026, 10:31:59 AM)

46.5731

+0.43 (+0.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner Change-0.39%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap112.49B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts77.33
Price Target58.84 (26.34%)
Short Float %0.39%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield 5.21%
Yearly Dividend2.26
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)3
Avg Revenue beat(12)8.5%
Revenue beat(16)7
Avg Revenue beat(16)20.74%
PT rev (1m)-5.49%
PT rev (3m)-4.88%
EPS NQ rev (1m)3.69%
EPS NQ rev (3m)3.22%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)-0.73%
Revenue NQ rev (1m)1.41%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 9.97
Fwd PE 9.22
P/S 1.42
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB 21.6
EV/EBITDA N/A
EPS(TTM)4.67
EY10.03%
EPS(NY)5.05
Fwd EY10.84%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.81
BVpS35.93
TBVpS2.16
PEG (NY)1.23
PEG (5Y)1.79
Graham Number61.44
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.87%
ROIC/WACC1.7
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y7.52%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI-ADR / SNY FAQ

What is the fundamental rating for SNY stock?

ChartMill assigns a fundamental rating of 5 / 10 to SNY.


Can you provide the valuation status for SANOFI-ADR?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI-ADR (SNY). This can be considered as Fairly Valued.


How profitable is SANOFI-ADR (SNY) stock?

SANOFI-ADR (SNY) has a profitability rating of 8 / 10.


What are the PE and PB ratios of SANOFI-ADR (SNY) stock?

The Price/Earnings (PE) ratio for SANOFI-ADR (SNY) is 9.97 and the Price/Book (PB) ratio is 1.3.


How sustainable is the dividend of SANOFI-ADR (SNY) stock?

The dividend rating of SANOFI-ADR (SNY) is 8 / 10 and the dividend payout ratio is 34.36%.